Recent News

• 05.29.2026 - At ASCO and EHA 2026, New Data Reinforce the Pivotal Role of clonoSEQ® MRD Testing Across Hematology Clinical Practice and Research
• 05.21.2026 - Adaptive Biotechnologies to Participate in Upcoming Investor Conferences
• 05.05.2026 - Adaptive Biotechnologies Reports First Quarter 2026 Financial Results
• 04.15.2026 - Adaptive Biotechnologies to Report First Quarter 2026 Financial Results on May 5, 2026

Recent Filings

• 05.20.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.15.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.15.2026 - 144 Report of proposed sale of securities
• 05.05.2026 - 8-K Current report
• 05.05.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.05.2026 - EX-99.1 EX-99.1
• 04.29.2026 - 4 Statement of changes in beneficial ownership of securities
• 04.24.2026 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.24.2026 - DEF 14A Other definitive proxy statements
• 04.24.2026 - 4 Statement of changes in beneficial ownership of securities